Navigation Links
Flatwire

ProductsFlatwire
Company GYRUS ACMI
Item Flatwire
Features 
  • Exclusive toggle-design locking system > Prevents flat-wire from inadvertently opening or closing
  • Strong, responsive flat-wire stone baskets > Enhanced opening strength
  • Advancement and retraction is almost friction-free > Delivers a true sense of basket movement
  • Open/close indicators > Clearly denotes basket position
  • Advanced thumb-slide design > Significantly reduces hand fatigue
  • Removable sheath and handle > Facilitates injection of contrast media without an additional catheter
  • Description Only SurLok combines precise control, enhanced basket and grasper strength, and the added security of a unique wire-locking mechanism. You can feel the difference. The SurLok flat-wire and grasper handle is designed to fit comfortably
    Info GYRUS ACMI
    Customer Service: (508) 804-2600
    Web site: http://www.acmicorp.com

    Related medicine products :

    1. Perc NCircle® Rapid Atraumatic PCNL Stone Extractor
    2. Sentinol™ Self-Expanding Nitinol Biliary Stent System
    3. Strange Cholangiography Set: With N-Circle® Nitinol Tipless Stone Extractor
    4. Common Duct Exploration Set: With N-Circle® Nitinol Tipless Stone Extractor
    5. N-Circle® Nitinol Tipless Stone Extractor
    6. NForce Nitinol Helical Stone Extractors
    7. Ncircle® Nitinol Tipless Stone Extractor with Unidex Handle
    8. Ncircle® Nitinol Tipless Stone Extractor - Helical Basket with Unidex Handle
    9. Ncircle® Nitinol Tipless Stone Extractors - RHR Replacement Stone Extractors
    10. Ncircle® Nitinol Tipless Stone Extractors with Delta Wire®
    11. Escape Nitinol Stone Retrieval Device
    TAG: Flatwire
    Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Service Corporation International Announces Schedule For Its Second Quarter 2009 Earnings Release and Conference Call 52397 1Service Corporation International Announces Schedule For Its Second Quarter 2009 Earnings Release and Conference Call 52397 2Biomodels Expands Efforts in Cancer Supportive Care Pulmonary Fibrosis 3B Preclinical Research Organization Names Dr Stephen T Sonis as Partner 13146 1Biomodels Expands Efforts in Cancer Supportive Care Pulmonary Fibrosis 3B Preclinical Research Organization Names Dr Stephen T Sonis as Partner 13146 2Is somatic hypersensitivity a predictor of irritable bowel syndrome 3F 52394 1Is somatic hypersensitivity a predictor of irritable bowel syndrome 3F 52394 2